PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
56.03
-1.56 (-2.71%)
Mar 13, 2025, 4:00 PM EST - Market closed
PROCEPT BioRobotics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Revenue | 224.5 | 136.19 | 75.01 | 34.47 | 7.72 | Upgrade
|
Revenue Growth (YoY) | 64.84% | 81.55% | 117.60% | 346.72% | 25.09% | Upgrade
|
Cost of Revenue | 87.4 | 65.14 | 37.93 | 18.61 | 8.97 | Upgrade
|
Gross Profit | 137.1 | 71.05 | 37.09 | 15.87 | -1.26 | Upgrade
|
Selling, General & Admin | 171.42 | 131.77 | 88.83 | 51.04 | 30.27 | Upgrade
|
Research & Development | 62.3 | 48.45 | 28.98 | 18.99 | 16.28 | Upgrade
|
Operating Expenses | 233.71 | 180.22 | 117.81 | 70.03 | 46.55 | Upgrade
|
Operating Income | -96.61 | -109.17 | -80.72 | -54.16 | -47.8 | Upgrade
|
Interest Expense | -4.18 | -4 | -5.18 | -5.81 | -5.26 | Upgrade
|
Interest & Investment Income | 10.9 | 7.55 | 2.5 | 0.08 | 0.18 | Upgrade
|
Other Non Operating Income (Expenses) | -1.51 | -0.28 | -0.49 | 0.05 | -0.14 | Upgrade
|
EBT Excluding Unusual Items | -91.41 | -105.9 | -83.9 | -59.85 | -53.02 | Upgrade
|
Other Unusual Items | - | - | -3.26 | - | - | Upgrade
|
Pretax Income | -91.41 | -105.9 | -87.15 | -59.85 | -53.02 | Upgrade
|
Net Income | -91.41 | -105.9 | -87.15 | -59.85 | -53.02 | Upgrade
|
Net Income to Common | -91.41 | -105.9 | -87.15 | -59.85 | -53.02 | Upgrade
|
Shares Outstanding (Basic) | 52 | 47 | 44 | 16 | 4 | Upgrade
|
Shares Outstanding (Diluted) | 52 | 47 | 44 | 16 | 4 | Upgrade
|
Shares Change (YoY) | 10.31% | 6.43% | 169.42% | 349.90% | 65.90% | Upgrade
|
EPS (Basic) | -1.75 | -2.24 | -1.96 | -3.63 | -14.47 | Upgrade
|
EPS (Diluted) | -1.75 | -2.24 | -1.96 | -3.63 | -14.47 | Upgrade
|
Free Cash Flow | -103.62 | -133.21 | -83.04 | -57.93 | -48.58 | Upgrade
|
Free Cash Flow Per Share | -1.99 | -2.82 | -1.87 | -3.51 | -13.26 | Upgrade
|
Gross Margin | 61.07% | 52.17% | 49.44% | 46.02% | -16.26% | Upgrade
|
Operating Margin | -43.04% | -80.16% | -107.61% | -157.12% | -619.44% | Upgrade
|
Profit Margin | -40.72% | -77.76% | -116.18% | -173.62% | -687.04% | Upgrade
|
Free Cash Flow Margin | -46.16% | -97.81% | -110.69% | -168.03% | -629.47% | Upgrade
|
EBITDA | -91.38 | -105.36 | -77.88 | -50.84 | -44.94 | Upgrade
|
EBITDA Margin | -40.70% | -77.36% | -103.82% | -147.48% | - | Upgrade
|
D&A For EBITDA | 5.23 | 3.81 | 2.84 | 3.32 | 2.86 | Upgrade
|
EBIT | -96.61 | -109.17 | -80.72 | -54.16 | -47.8 | Upgrade
|
EBIT Margin | -43.04% | -80.16% | -107.61% | -157.12% | - | Upgrade
|
Advertising Expenses | 0.5 | 0.3 | 0.1 | 0.1 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.